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Abstract
Background: Volumetric muscle loss caused by trauma or after tumour surgery exceeds the natural regeneration
capacity of skeletal muscle. Hence, the future goal of tissue engineering (TE) is the replacement and repair of lost
muscle tissue by newly generating skeletal muscle combining different cell sources, such as myoblasts and
mesenchymal stem cells (MSCs), within a three-dimensional matrix. Latest research showed that seeding skeletal
muscle cells on aligned constructs enhance the formation of myotubes as well as cell alignment and may provide a
further step towards the clinical application of engineered skeletal muscle.
In this study the myogenic differentiation potential of MSCs upon co-cultivation with myoblasts and under
stimulation with hepatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) was evaluated. We further
analysed the behaviour of MSC-myoblast co-cultures in different 3D matrices.
Results: Primary rat myoblasts and rat MSCs were mono- and co-cultivated for 2, 7 or 14 days. The effect of
different concentrations of HGF and IGF-1 alone, as well as in combination, on myogenic differentiation was
analysed using microscopy, multicolour flow cytometry and real-time PCR. Furthermore, the influence of different
three-dimensional culture models, such as fibrin, fibrin-collagen-I gels and parallel aligned electrospun poly-ε-
caprolacton collagen-I nanofibers, on myogenic differentiation was analysed. MSCs could be successfully
differentiated into the myogenic lineage both in mono- and in co-cultures independent of HGF and IGF-1
stimulation by expressing desmin, myocyte enhancer factor 2, myosin heavy chain 2 and alpha-sarcomeric actinin.
An increased expression of different myogenic key markers could be observed under HGF and IGF-1 stimulation.
Even though, stimulation with HGF/IGF-1 does not seem essential for sufficient myogenic differentiation. Three-
dimensional cultivation in fibrin-collagen-I gels induced higher levels of myogenic differentiation compared with
two-dimensional experiments. Cultivation on poly-ε-caprolacton-collagen-I nanofibers induced parallel alignment of
cells and positive expression of desmin.
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Conclusions: In this study, we were able to myogenically differentiate MSC upon mono- and co-cultivation with
myoblasts. The addition of HGF/IGF-1 might not be essential for achieving successful myogenic differentiation.
Furthermore, with the development of a biocompatible nanofiber scaffold we established the basis for further
experiments aiming at the generation of functional muscle tissue.
Keywords: IGF-1, HGF, Mesenchymal stem cells, Myogenic differentiation, PCL-collagen nanofibers, Skeletal muscle
tissue engineering
Background
Approximately one-half of our body consists of skeletal
muscle, which is responsible for executing every single
action we undertake [1]. Skeletal muscle has the ability
to regenerate in response to damage by activating satel-
lite cells resting beneath the basal lamina of adult skel-
etal muscle [2, 3]. However, this specific regeneration
capacity is limited to only small wounds, whereas volu-
metric muscle loss caused by trauma or surgery requires
remarkable efforts, such as free autologous muscle flap
transplantation, which always come along with inevitable
morbidity at the donor site [4–6]. This is where skeletal
muscle tissue engineering (TE) might be a future goal,
trying to mimic the structure and function of skeletal
muscle [4–6].
For successfully generating muscle tissue in vivo, not
only easily expandable cells but also a suitable biocom-
patible matrix needs to be generated. Muscle satellite
cells offer the best characteristics for muscle TE, being
capable of self-renewal and regeneration upon a variety
of stimuli [7, 8]. However, multiple passaging decreases
their differentiation capacity making their clinical applic-
ability as single cell source difficult [9, 10]. Mesenchymal
stem cells (MSCs) from the bone marrow may represent
a promising alternative cell source for muscle TE since
they can easily be harvested, expanded widely without
losing their differentiation ability and autologous trans-
plantation for future clinical applications does not come
along with any risk of rejection [11, 12]. It has been de-
scribed that MSCs can be differentiated towards the
myogenic lineage by expressing muscle specific markers,
even though their myogenic potential is limited [13–15].
Myogenic differentiation of MSCs alone might not be
sufficiently satisfying, but they still represent an attract-
ive cell source for co-cultivation with myoblasts. The ap-
plication of MSCs co-cultivated with myoblasts has
previously been investigated and it was shown that
MSCs are able to fuse with myoblasts and contribute to
the muscle regeneration process [13]. Moreover, it has
been demonstrated that the addition of human MSCs to
skeletal myoblasts cell-sheet in the ischemic cardiomy-
opathy model intensifies the release of different cyto-
kines such as HGF and VEGF [16]. MSCs are not only
known to secrete several growth factors involved in the
muscle regeneration process such as basic fibroblast
growth factor (bFGF), hepatocyte growth factor (HGF)
or insulin-like growth factor 1 (IGF-1), but they also
stimulate myoblast migration, proliferation, differenti-
ation and cell survival upon co-cultivation [13, 16, 17].
Previous studies showed that stimulation with different
supplements such as bFGF and dexamethasone potenti-
ates MSC and myoblast differentiation capacity [18].
However, the effects of HGF and IGF-1 regarding the
myogenic differentiation of MSC and myoblast co-
cultures still require further investigation. It is well
known that HGF activates satellite cells binding to the c-
met tyrosine kinase receptor and stimulating different
downstream targets [19]. While HGF primarily induces
the proliferation of satellite cells, IGF-1 both activates
proliferation and differentiation through binding to the
IGF-1 receptor (IGF-1.R) [20]. The majority of circulat-
ing IGF-1 is bound to specific IGF-binding proteins
(IGFBPs), a family of secreted proteins binding IGF-1
with greater affinity than IGF-1.R [21, 22]. There are dif-
ferent isoforms of IGFBPs and their exact roles are not
clarified yet: While IGFBP4 mostly inhibits IGF stimula-
tion, IGFBP5 acts through and independently of IGF and
can therefore even potentiate or inhibit myogenic differ-
entiation, and IGFBP6 is mostly expressed in proliferat-
ing cells [20, 21, 23, 24].
As mentioned above, successful generation of skeletal
muscle needs both a suitable cell source as well as a bio-
compatible matrix. For optimally mimicking the in vivo
structure of skeletal muscle and creating an applicable
system for TE, a three-dimensional (3D) construct is
needed. Different matrices have been studied for muscle
TE applications, e.g. Heher et al. developed aligned fibrin
fibrils in a 3D scaffold by applying static mechanical strain,
demonstrating aligned myotube formation of myogenic
precursor cells [25]. Further, Choi et al. demonstrated that
cultivation of human skeletal muscle cells on unidirec-
tional electrospun poly-ε-caprolacton (PCL)-collagen
nanofiber meshes enhances myotube formation as well as
skeletal muscle cell organization [26]. In previous studies,
comparing fibrin-collagen-I gels with electrospun collagen
nanofibers, good proliferation as well as differentiation of
myoblasts could be shown, with parallel oriented nanofi-
bers representing the most promising matrix [27].
Witt et al. BMC Cell Biology  (2017) 18:15 Page 2 of 16
One aim of this study is to investigate the influence of
different concentrations as well as the combination of
HGF and IGF-1 on myogenesis using co-cultures of
MSCs and myoblasts as well as MSC monocultures. The
three major myogenic key differentiation markers ana-
lysed in this study are, amongst others, myocyte enhan-
cer factor 2 (MEF2), myosin heavy chain 2 (MyHC2)
and alpha-sarcomeric actinin (ACTN2). MEF2 is a tran-
scription factor, which interacts with members of the
MyoD family of basic helix–loop–helix (bHLH) proteins
to activate the skeletal muscle differentiation program. It
plays a central role in activating pathways responsible
for cell division, differentiation and death [28]. MEF2 is
upregulated especially when cells enter the differentiation
pathway and required in response to injury for adult myo-
genesis [18, 29–31]. However MEF2 seems to play a cru-
cial role in myogenesis, its effects on MSC myoblast co-
cultures have not been investigated profoundly so far.
ACTN2, a cytoskeletal protein, stabilises the muscle con-
tractile apparatus and is essential for developing the sarco-
mere. Such is, MyHC2, which constitutes sarcomere thick
filaments and functions as a molecular motor protein in
skeletal muscle. Both factors are indispensable for the for-
mation of differentiated skeletal muscle [18, 32–34]. Their
expression is proof for generating skeletal muscle. Even
though, their behaviour concerning myogenic differenti-
ation in MSC and myoblast co-cultures is not sufficiently
studied and therefore of high interest.
We further analysed the behaviour of MSC-myoblast
co-cultures in 3D fibrin and fibrin-collagen-I gels, espe-
cially in light of myogenic differentiation. As a final step,
parallel-aligned electrospun PCL-collagen-I nanofibers
were developed and cultivated with MSC-myoblast co-
cultures stimulated with HGF and IGF-1 for testing the
applicability for future in vivo studies.
Methods
Myoblast cell culture
Satellite cells were isolated from hind limb muscles of male
Lewis rats (Charles River, Wilmington, Massachusetts,
USA) as described previously [18]. For cell culture, Ham’s
F-10 medium (Gibco, Carlsbad, California, USA) contain-
ing 25% FCS (Biochrom GmbH, Berlin, Germany), 1.25%
Penicillin/Streptomycin (Biochrom GmbH) and 2.5 ng/ml
bFGF (Peprotech, Hamburg, Germany) was used. The
medium was changed every second day. Myoblasts of pas-
sage 3 were used for all experiments. To verify the myo-
genic phenotype of isolated cells, staining with the highly
muscle-specific MyoD nuclear protein (5.8.A, Abcam,
Cambridge, UK) was performed (see Additional file 1) [35].
MSC cell culture
Rat MSCs were isolated from the bone marrow of male
Lewis 1WR2 rats as described previously [36]. MSCs
were stably transduced with green fluorescent protein
(GFP) for cell labelling, and GFP-positive clones were
expanded as described before by Lange et al. [36, 37].
Phenotype was assessed by their ability to differentiate
into chondrocytes, adipocytes and osteocytes [36, 37].
MSCs were cultured in growth medium (DMEM Ham’s
F-12, 10% FCS, 1% L-Glutamin, 1% P/S; all from Biochrom
GmbH) and were used at passage 11 and 12 for all experi-
ments. Medium was changed every second day.
Differentiation conditions
Basic differentiation medium (DMEM/Ham’s F-12 + 2%
donor horse serum (DHS) + 1% L-Glutamin + 1% P/S
(Biochrom GmbH) + 0.4 μg/ml dexamethasone (Sigma
Aldrich, St. Louis, Missouri, USA) + 1 ng/ml bFGF
(Peprotech)) was supplemented with different concen-
trations of HGF (R&D Systems, Minneapolis, Minnesota,
USA; 10, 30, 60, 100 ng/ml) and IGF-1 (Peprotech; 5, 10,
30, 60 ng/ml) and the combination of 10 ng/ml HGF +
10 ng/ml IGF-1. Cells were differentiated in mono- and
co-cultures of myoblasts and MSCs for 2, 7 and 14 d
(d = day). For co-culture experiments, cells were seeded in
a ratio of 1:1 in 12-well culture plates at a density of 6 ×
104 cells in expansion medium (DMEM Ham’s F-12, 10%
FCS, 1% L-Glutamin, 1% P/S). After 24 h, medium was re-
placed by differentiation medium. Medium was changed
every second day.
For each experiment, myoblasts from three different
isolations were used.
Multicolour flow cytometry
Multicolour flow cytometry was carried out on a
FACSCalibur cytometer with cell Quest software and
analysed with Flowjo software (Tree Star, Ashland,
Oregon, USA).
Mono- and co-cultures of myoblasts and MSCs were
seeded at a density of 1.5 × 105 in a 25-cm2 flask
(Greiner, Frickenhausen, Germany) and cultured with
differentiation media containing HGF 10 ng/ml and
IGF-1 10 ng/ml and stimulated for 2 d and 14 d. Cells
were detached and blocked in 5% FCS for 15 min. The
pellet was picked up in 100-μl Cytofix/Cytoperm solu-
tion (Cytofix/Cytoperm Fixation/Permeabilization Kit;
BD Biosciences, San Jose, California, USA) and incu-
bated for 20 min at 4 °C. Cells were washed with BD
Perm/Wash buffer. The cell pellet was incubated for
30 min at 4 °C with primary antibodies solved in 100-μl
BD Perm/Wash Buffer in a concentration of 1:50 (anti-
alpha-sarcomeric actinin (EA-53, Abcam), anti-MEF2
(MEF2A, B-4, Santa Cruz Biotechnology, Dallas, Texas,
USA), all mouse-anti-rat IgG1). As a secondary antibody,
PE anti-mouse IgG1 (BD Biosciences) was used (1:50,
for 30 min at 4 °C). For further flow cytometry analysis,
cells were picked up in PBS (Biochrom GmbH) with 2%
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FCS and 0.1% NaN3. Controls included unstained cells
for negative and L6-myoblasts (L6-Mb) cell line (Ameri-
can Type Culture Collection, ATCC, Manassas, Virginia,
USA) for positive control. As the isotype control, PE-
labelled anti-mouse IgG1 (BD Biosciences) was used. For
MSC and myoblast co-cultures as well as myoblast
monocultures, myoblasts of three different isolations
were used. Experiments with MSC monocultures were
performed once.
Immunocytochemistry
Cells of each group were seeded at a density of 1.2 × 104
cells in expansion medium. After 24 h, the medium was
replaced by differentiation medium. After fixation with
ice-cold methanol, slides were washed and incubated in
blocking buffer consisting of PBS with 1.5% FCS and
0.25% TritonX (Carl Roth GmbH, Karlsruhe, Germany)
for 1 h at room temperature. After washing with TBS-T
buffer (100 mM Tris and 60 mM NaCl in distilled water,
1 ml Tween20 per 1 L; pH 7.6), slides were covered with
primary antibodies (anti-desmin (AB-1 (D33), Thermo
Fisher Scientific, Runcorn, Cheshire, UK), anti-alpha-
sarcomeric actinin (EA-53, Abcam), anti-MEF2 (MEF2A,
B-4, Santa Cruz Biotechnology), anti-myosin heavy chain
2 (MYSN02, MyHC2, Thermo Fisher Scientific)) and
diluted 1:50 in blocking buffer for 1 h at room tem-
perature. As secondary antibody, Alexa Fluor 594 goat-
anti-mouse IgG1 (Invitrogen, Karlsruhe, Germany) was
used at 1:200 for 30 min at room temperature. Probes
were counterstained with DAPI 1:1000 (Diamidine-
phenylindole-dihydrochloride, Applied Science/Roche,
Indianapolis; Indiana, USA) for 5 min. Slides were subse-
quently analysed and digitally photographed with a fluor-
escence microscope (IX83, cellSens software, Olympus,
Hamburg, Germany). L6-Mb served as the positive con-
trol. An isotype control was performed using mouse IgG1
(BD Biosciences).
RNA isolation and quantitative PCR analysis
In each group the expression rate of DES (desmin),
MYOG (myogenin), MEF2D (myocyte enhancer factor
2D), MyHC2 (myosin heavy chain 2), ACTN2 (alpha
actinin skeletal muscle 2), IGFBP4, 5, 6 was analysed. As
housekeeping gene RPL13a (ribosomal protein L13a)
was used. RNA of all probes was extracted using the
RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) ac-
cording to the manufacturer’s protocols. RNA was
reverse-transcribed into cDNA using a QuantiTect
Reverse Transcription Kit and a Sensiscript Reverse
Transcription Kit (both from Qiagen GmbH). cDNA
was amplified through quantitative real-time PCR using
SsoAdvanced Universal SYBR Green PCR Supermix
(Bio-Rad, Hercules, California, USA) and Light Cycler
(Bio-Rad iCycler iQ5). Probes were analysed in triplicates
and variations of more than 1.5 threshold cycles were
dismissed. Data evaluation was performed using the
2-ΔΔCt method. The primer sequences used are given
in Table 1.
Cell culture in 3D fibrin and fibrin-collagen-I gels
Fibrinogen and thrombin (Tisseel VH, S/D kit, Baxter
AG, Vienna, Austria) were dissolved according to the
manufacturer’s instructions. Collagen (rat tail collagen
type I, BD Biosciences) for the fibrin-collagen gels was
equilibrated to pH 7 prior to use. A co-culture of
100.000 CM-DiI (Invitrogen) labelled rat myoblasts and
GFP-transduced rat MSCs at a ratio of 1:1 was mixed
with either a fibrinogen-medium solution or fibrinogen-
collagen-medium solution. Cell suspensions were mixed
1:1 with thrombin (final concentration of 6 IU) in a 24-
well plate. Each gel had a total volume of 700 μl with a
fibrin concentration of either 2.5 or 5 mg/ml. In the
fibrin-collagen gels the collagen concentration was
0.25 mg/ml. The gels were finally covered with 400 μl of
differentiation medium containing 0.1 TIU/ml aprotinin.
After 2 and 7 d, gels were frozen in liquid nitrogen and
minced with mortar and electrical mixer (IKA Werke,
Staufen, Germany). Gels were further homogenised with
Trizol (Life Technologies, Carlsbad, California, USA)
and chloroform, and RNA was purified as described pre-
viously. A differentiation medium with and without
HGF/IGF-1 was used.
Electrospinning of PCL-collagen-I nanofibers and cell
seeding
PCL (Sigma Aldrich) was dissolved at a ratio of 2:1 with
bovine collagen type 1 (Symatese, Chaponost, France) in
ethanol (VWR, Darmstadt, Germany) 90% at a concen-
tration of 10% w/v (distance needle tip counter elec-
trode: 20 cm). Parallel nanofibers were electrospun on a
counter electrode consisting of two parallel arranged
beams (distance between the beams: 3 cm) on a standard
electrospinning machine (Linari, Pisa, Italy). Afterwards,
Table 1 Primer sequences
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fibres were collected from the beams using glass plates
(1 cm diameter). Nanofibers were electrospun with a
voltage of 20 kV and a flow rate of 1 ml/h. Twelve hours
before cell seeding, probes sterilised in 70% ethanol,
washed with PBS afterwards and soaked in DMEM
Ham’s F-12 for approximately 1 h at 37 °C. Scaffolds
were seeded with 100 μl expansion medium containing
50,000 MSCs and myoblasts at a ratio of 1:1. After an in-
cubation time of 3 h at 37 °C, wells were filled with 1 ml
of expansion medium. After 24 h, scaffolds were trans-
ferred into new well plates and stimulated with basic dif-
ferentiation medium containing HGF and IGF-1 for 7 d.
To analyse cell morphology and orientation, scanning
electron microscopy and phase contrast microscopy
(Olympus, Hamburg, Germany) was used.
Scanning electron microscopy
Microstructural analysis of the scaffolds was performed
using an Auriga Fib-SEM (Zeiss, Oberkochen,
Germany). For this, the fibres were placed on aluminium
stubs of 8 mm diameter. The probes were then sputter-
coated with gold for 1 min using an EMITECH-K550
sputter coater at an operating pressure of 7 × 102 bar
and a deposition current of 20 mA. The SEM images
were taken at an acceleration voltage of 2 kV and a
working distance of approximately 8 mm.
Time-lapse microscopy
GFP-MSC and CM-DiI-myoblasts were seeded in a ratio
of 1:1 in 12-well culture plates at a density of 6 × 104
cells in expansion medium. After 6 h, the medium was
replaced by basic differentiation medium containing
dexamethasone and bFGF. Culture plate was placed in
an Olympus cell vivo microscopy system (IX83/cellVivo,
cellSens software, Olympus, Hamburg, Germany). Co-
cultures were cultivated under 37 °C and 5% CO2 for ap-
proximately 5 d. Four different positions were deter-
mined using the Olympus cellSens software. A picture of
each position was taken every 10 min.
Statistical analysis
Data are expressed as a mean–standard deviation. Statis-
tical analysis was performed using SPSS 21.0 for
Windows (SPSS, Chicago, Illinois, USA).
Results were statistically interpreted by one-way ana-
lysis of variance (ANOVA) and Tukey HSD test as a post
hoc test. Normal distribution was confirmed using the
Shapiro Wilk test. In the case of no normal distribution,
the nonparametric Kruskal-Wallis test and the Mann-
Whitney U-test were used. For comparing samples over
different time points, ANOVA for repeated measure-
ments was used.
The level of statistical significance was set to p ≤ 0.05.
A p-value ≤ 0.01 was considered to be highly significant.
Results
Effects of HGF on mRNA level of different myogenic
markers in MSCs co-cultivated with primary myoblasts
and in monocultures
MSC and primary rat myoblasts were co- and monocul-
tured in basic differentiation medium containing HGF
and in control medium without HGF for 2 d and 7 d.
Expression of different myogenic markers could be ob-
served under all conditions. In co-cultures, the early
stimulation (2 d) with HGF demonstrated significant
and highly significant upregulations of MEF2 using 10,
30 and 60 ng/ml compared with late stimulation (7 d). A
dose-dependent decrease of MEF2 could be demon-
strated after 2 d (Fig. 1a). Both MEF2 and ACTN2 ex-
pressions were equal or upregulated during early
stimulation compared with unstimulated control groups
(Fig. 1a–b). In MSC monocultures, the strongest
MEF2 expression (1.6 ± 0.6-fold) could be achieved
with 10 ng/ml HGF after stimulation for over 7 d.
Except in groups with 30 ng/ml HGF, long-term
stimulation achieved almost equal or higher levels of
MEF2 and ACTN2 in MSCs compared with controls
(Fig. 1c–d). Varying results were observed in myoblast
monocultures: Early stimulation with 10–60 ng/ml
HGF induced a concentration-dependent upregulation
of MEF2 and ACTN2 (Fig. 1e–f ). Comparing the
three different cell groups, it could be demonstrated
that early stimulation with HGF increased the levels
of myogenic markers especially in co-cultures and
myoblast monocultures, whereas in MSCs this oc-
curred during long-term stimulation.
Effects of IGF-1 on mRNA level of different myogenic
markers in MSC co-cultivated with primary myoblasts and
in monocultures
MSC and primary rat myoblasts were co- and monocul-
tured in basic differentiation medium containing IGF-1
and in control medium without IGF-1 for 2 d and 7 d.
Expression of MEF2 and ACTN2 could be observed
under all conditions. A highly significant and significant
higher expression of MEF2 could be detected in MSC
and myoblast co-cultures after 2 d compared with 7 d in
the 10 and 30 ng/ml IGF-1 group (Fig. 2a). ACTN2 ex-
pression was upregulated during early stimulation com-
pared with unstimulated control groups (Fig. 2b). In
MSC monocultures, stimulation with 60 ng/ml IGF-1
over 2 d induced the strongest upregulation of MEF2
(1.2 ± 0.4-fold) (Fig. 2c). ACTN2 expression was overall
increased during early stimulation (Fig. 2d). Mb mono-
cultures were influenced positively by early stimulation
with IGF-1: An overall increase of MEF2 and ACTN2
was observed after 2 d. Long-term stimulation showed
no increase of myogenic markers (Fig. 2e–f ). During
early stimulation, MEF2 expression increased in co-
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cultures and myoblast monocultures the most. Highest
ACTN2 expressions were seen in myoblast monocul-
tures. The expression of ACTN2 in MSC monocultures
and co-cultures was similar.
Influence of the combined stimulation of HGF and IGF-1
on mRNA level
In MSC monocultures, as well as in co-cultures with
myoblasts, higher expressions of DES compared with
myoblasts (=1) could be observed. Cultivation in HGF/
IGF-1 free medium achieved highest levels of DES
(MSC: 218.5 ± 219-fold; MSC +Mb: 64.5 ± 62-fold) after
2 d. During early stimulation, MSC monocultures
showed overall higher levels of DES than co-cultures
(Fig. 3a). MYOG expression was upregulated under HGF
stimulation compared with myoblasts under HGF after
14 d. MYOG could only be detected in one out of three
experiments and merely in co-cultures (Fig. 3b). After
14 d, in co-cultures, highest levels of ACTN2 (5.9 ± 14-
fold) and MyHC2 (4.8 ± 2.3-fold) could be observed
under IGF-1 stimulation. IGFBP4 expression increased
in co-and monocultures with growth factors compared
with cultivation in control medium without HGF/IGF-1
(Fig. 3e). IGFBP5 and -6 expression in co-cultures was
elevated in the IGF-1 group compared with groups
without growth factors. In MSC monocultures, hardly
any expression of IGFBP5 and -6 could be detected
(Figs. 3f–g).
Myogenic differentiation and fusion of MSCs co-cultured
with primary myoblasts under the influence of HGF and
IGF-1
With fluorescence microscopy, the myogenic differenti-
ation potential of MSCs mono- and co-cultured with
myoblasts was analysed under stimulatory and non-
stimulatory effects after 7 and 14 d. A positive staining
for muscle specific marker MyHC2, could be detected
under HGF effects as well as the other tested conditions
(Fig. 4a, b). MSC involvement in the formation of pos-
sibly multinucleated cells was verified by their green
fluorescence protein expression, as these cells had been
stable transduced prior to co-cultivation (Fig. 4b; arrows)












































































































































Fig. 1 Expression of MEF2 and ACTN2 under different concentrations of HGF. Real-time PCR of MSC and myoblast (Mb) mono- and co-cultures
under HGF stimulation as well as in unstimulated controls. Expressions are demonstrated in x-fold difference compared with unstimulated cells
cultivated in basic differentiation medium (control = 1) using the 2-ΔΔCt method. Markers are presented with mean +/- SD. a Significant and highly
significant higher expression of MEF2 in co-cultures after 2 d compared with 7 d using 10, 30 and 60 ng/ml HGF. b In co-cultures, ACTN2 expression
was upregulated during early stimulation compared with unstimulated control groups. 100 ng/ml HGF over 7 d induced the strongest ACTN2
expression. c Strongest MEF2 expression in MSC monocultures could be achieved with 10 ng/ml HGF after stimulation for over 7 d. d Seven-day
stimulation with 10, 60 and 100 ng/ml HGF induced almost equal or higher levels of ACTN2 in MSC monocultures compared with 2 d stimulation.
e-f In Mb, a dose-dependent increase in MEF2 (e) and ACTN2 (d) expression was demonstrated from 10 to 60 ng/ml HGF during early stimulation.
Increased levels of MEF2 and ACTN2 under HGF during early stimulation in co-cultures and Mb monocultures compared with unstimulated controls.
Mb of three different isolations were used in three independent experiments. Three replicates of each were used. (** = p≤ 0.01). (* = p≤ 0.05)
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(For single stainings see Additional files 2 and 3). Fur-
thermore, myogenic differentiation could be demon-
strated via positive staining for MEF2, expressed
especially during muscle differentiation. Here, data of
unstimulated controls are shown (Fig. 5) (For single
stainings see Additional file 4).
Further myogenic differentiation was evaluated with
flow cytometry analysis of MEF2 and ACTN2 (Fig. 6).
MSC and myoblast co-cultures, MSC monocultures,
myoblast monocultures and L6-Mb as positive controls
were stimulated with HGF + IGF-1 or cultivated in con-
trol medium. After 14 d of cultivation, MEF2 expression
in HGF + IGF-1 co-cultures showed a highly significant
increase from 72.3% after 2 d up to 93.6% after 14 d. Ex-
pression of MEF2 in control groups did not increase sig-
nificantly from 79% (2 d) to 91.3% (14 d). In MSC
monocultures and L6-Mb, MEF2 expression was also
upregulated after 14 d. Co-cultures and MSC monocul-
tures achieved equal levels of MEF2 compared with L6-
Mb after 14 d, both in HGF + IGF-1 and in control
medium. Myoblast monocultures showed a decrease of
MEF2 over time (Fig. 6a).
The expression of ACTN2 in co-cultures with HGF +
IGF-1 was highly significantly upregulated (1.5-fold)
from 2 to 14 d. Controls also showed a highly significant
upregulation of ACTN2 from 50.6% after 2 d up to
67% after 14 d, but lower than the HGF + IGF-1
groups after 14 d (73.9%). In MSC monocultures, an
increased ACTN2 expression was observed after 14 d
compared with 2 d. Comparable to MEF2 expression,
myoblasts showed a decrease in the myogenic marker
over time. Co-cultures and MSC monocultures
achieved equal levels of ACTN2 compared with L6-
Mb after 14 d, both in HGF + IGF-1 and in the con-
trol medium (Fig. 6b).
Via microscope, we recorded the cell behaviour of
MSC and myoblast co-cultures over a time period of
5 d. Signs of cell fusion between both cell sources
could be seen (see Additional file 5). Considering that
muscle repair and newly formation of skeletal muscle










































































































































Fig. 2 Expression of MEF2 and ACTN2 under different concentrations of IGF-1. Real-time PCR of MSC and myoblast (Mb) mono- and co-cultures
under IGF-1 stimulation as well as in unstimulated controls. Expressions are demonstrated in x-fold difference compared with unstimulated cells
cultivated in basic differentiation medium (control = 1) using the 2-ΔΔCt method. Markers are presented with mean +/- SD. a Overall higher
expressions of MEF2 in co-cultures under the different IGF-1 concentrations compared with unstimulated conditions after 2 d. Significant and
highly significant higher levels of MEF2 after 2 d compared with 7 d using 10 and 30 ng/ml IGF-1. b Overall higher expressions of ACTN2 in co-
cultures under the different IGF-1 concentrations compared with unstimulated conditions after 2 d. c Stimulation with 60 ng/ml IGF-1 over 2 d
induced the strongest upregulation of MEF2 in MSC monocultures. d Overall increased ACTN2 expression in MSC monocultures was observed
during early stimulation, with highest levels under 10 ng/ml IGF-1. e-f Early stimulation with IGF-1 induced higher MEF2 (e) and ACTN2 (f) expressions
in Mb monocultures compared with controls, with strongest expression under 30 ng/ml IGF-1. Increased MEF2 expression in co-cultures and Mb
monocultures after 2 d compared with unstimulated controls. The highest MEF2 and ACTN2 levels were detected in Mb monocultures. Mb of three
different isolations were used in three independent experiments. Three replicates of each were used. (** = p≤ 0.01). (* = p≤ 0.05)
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usually happens upon fusion of myoblasts, this might
be a further step towards the generation of muscle
tissue [17].
Effect of 3D scaffolds on myogenic differentiation of MSC
and myoblast co-cultures
MSCs and myoblasts were cultivated in different 3D
gels, consisting of either 5 or 2.5 mg/ml fibrin alone or
in combination with collagen I. After 2 and 7 d, gene ex-
pression analysis of myogenic differentiation markers
was performed. MEF2 expression decreased significantly
in 5 mg/ml fibrin gels and 2.5 mg/ml fibrin-collagen-I
gels and highly significantly in 2.5 mg/ml fibrin gels over
time, but not in 5 mg/ml fibrin-collagen-I gels, which
experienced a highly significant increase (Fig. 7a).
Comparable to MEF2, ACTN2 expression decreased
over time in fibrin gels and increased highly significantly
in 5 mg/ml fibrin-collagen-I gels (Fig. 7b).
A range of myogenic markers (MEF2, MyHC2,
ACTN2, MYOG, IGFBP4, -5, -6) was analysed in co-
cultures cultivated in HGF + IGF-1 for 2 d and compared

















































































































































Fig. 3 Expression of myogenic differentiation markers and IGFBPs under the influence of HGF and IGF-1. Real-time PCR of MSC and myoblast
(Mb) mono- and co-cultures stimulated with HGF + IGF-1, HGF, IGF-1 or cultivated in unstimulated controls. Expressions are demonstrated in
x-fold difference compared with Mb (=1) using the 2-ΔΔCt method. Markers are presented with mean +/- SD. a After 2 d, the strongest DES
upregulation was demonstrated in unstimulated controls. Throughout all conditions in MSCs, much higher levels of DES compared with co-
cultures and Mb were observed. b After 14 d, strongest MYOG expression was detected under HGF stimulation compared with control myoblasts.
MYOG could only be detected in one out of three experiments. c The highest expression of ACTN2 was observed in IGF-1 stimulated groups, both
in co-cultures and MSC monocultures. d The strongest upregulation of MyHC2 in co-cultures was observed under IGF-1 stimulation. In MSC
monocultures, the levels of MyHC2 remained under all conditions lower than Mb. e In co-cultures, the highest IGFBP4 levels were observed under
IGF-1 stimulation. In MSC monocultures, HGF induced the strongest upregulation of IGFBP4. f In co-cultures, the highest IGFBP5 levels were
observed under IGF-1 stimulation. In MSC monocultures, the expression of IGFBP5 remained lower under all conditions compared with Mb. g In
both cell groups, the levels of IGFBP6 were overall lower than in control Mb. Mb of three different isolations were used in three independent
experiments. Three replicates of each were used
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slight, significant forMyHC2, upregulation of gene expres-
sion compared with control was detected (Fig. 7c).
MSC-myoblast co-cultures were further cultivated on
parallel-aligned PCL-collagen-I-nanofiber scaffolds for 7 d
and stimulated with HGF + IGF-1. SEM images of the
PCL-collagen-I nanofibers showed a parallel-orientated
scaffold (Fig. 8a, b). Using SEM and fluorescence micros-
copy, the attachment, proliferation and parallel alignment
of the cells could be observed (Fig. 8c–d). Positive
myogenic differentiation of cells growing on the scaffold
could be demonstrated with desmin immunocytochem-
istry (Fig. 8e).
Discussion
The aim of this study was to examine the effects of HGF
and IGF-1 on MSC and myoblast co-cultures, as well as
monocultures, and to investigate the cell–cell interac-
tions in a 3D-matrix.
Time-dependent effect of HGF and IGF-1 on myogenic
differentiation of mono- and co-cultures
We investigated the influence of different concentrations
of HGF and IGF-1 on MSC and myoblast co-cultures, as
well as monocultures, compared with cells cultivated in
HGF/IGF-1 free medium, analysing MEF2 and ACTN2
expression. Due to sometimes high standard deviations,
some of the comparisons showed no statistically signifi-
cant differences. An explanation for higher standard de-
viations might be that sometimes we could only isolate
small amounts of RNA that perhaps do not fully reflect
the total RNA of the analysed group and therefore









































Fig. 4 Fluorescence microscopy of MyHC2 in co-cultures. A positive
staining of MyHC2, a muscle-specific major contractile protein, in
MSC and Mb co-cultures under HGF stimulation for 7 d (a) and 14 d
(b). Merge of DAPI (blue, nuclear staining), GFP (green, transduced
MSC) and MyHC2 (red, with Alexa fluor 594 as secondary antibody).
a The beginning formation of multinucleated cells could be observed
under HGF stimulation. MSCs show positive expression of MyHC2
(arrows). Scale bars represent 20 μm. Magnification 400x. b The
formation of multinucleated cells could be observed under HGF
stimulation. It seems that MSCs are involved in the formation






















Fig. 5 Fluorescence microscopy of MEF2 in co-cultures after 14 d. A
positive staining of MEF2, a co-transcriptional factor expressed
during muscle differentiation, in MSC and Mb co-cultures in control
groups without HGF/IGF-1 after 14 d. Merge of DAPI (blue, nuclear
staining), GFP (green, transduced MSC) and MEF2 (red, with Alexa
fluor 594 as secondary antibody). The red fluorescence demonstrates
the characteristic perinuclear localisation of MEF2. Scale bars represent
50 μm. Magnification 200x
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In our study, stimulation with different concentrations
of the growth factors, revealed, especially under HGF, no
clear trend regarding the expression of myogenic
markers. It is well known that HGF both plays a role in
proliferation as well as differentiation of skeletal muscle
cells [38]. Yamada et al. described low expression of
myogenin mRNA under 2.5 ng/ml as well as under ex-
tremely high (500 ng/ml) HGF concentrations, suggest-
ing decreased myogenic differentiation [38, 39]. Walker
et al. detected decreased Myosin Heavy Chain expression
under 2 ng/ml HGF, but increased levels at 10 ng/ml,
while Gal-Levi et al. showed lower MyHC levels with in-
creased HGF concentrations (20–50 ng/ml) [38, 40]. A
variety of studies have been made, trying to define the in-
fluence of different concentrations of HGF on skeletal
muscle development, which has not been clarified yet.
In our study, early stimulation with HGF or IGF-1
achieved almost equal or increased levels of MEF2 and
ACTN2 in co-cultures and myoblast monocultures,
under all concentrations. Focussing on the temporal
course, MEF2 expression decreased significantly and
highly significantly under HGF and IGF-1 influence in
co-cultures. According to previously published findings,
it may be suggested that too high concentrations of ei-
ther of the added growth factors could negatively influ-
ence myogenic differentiation [41–44]. Differences were
detected regarding MSC monocultures: especially long-
term stimulation with HGF resulted in higher myogenic
marker expression compared with unstimulated con-
trols. During early stimulation in MSCs, only 30 ng/ml
HGF achieved elevated levels of MEF2 compared to un-
stimulated controls, being opposite to the other groups.
Regarding that the result was not statistically significant,
together with a high range of standard deviation and the
fact that sometimes only small amounts of RNA could
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Fig. 6 Flow cytometry analysis of MEF2 and ACTN2 in MSC and myoblast co-cultures, MSC and myoblast monocultures and L6-myoblasts. Markers
are presented with mean +/- SD. a Highly significant upregulation of MEF2 in co-cultures from 2 to 14 d of stimulation with HGF + IGF-1. Higher
levels of MEF2 in MSC monocultures could be observed in stimulated and control groups compared with L6-myoblasts. The expression of MEF2
was slightly downregulated after 14 d in myoblast (Mb) monocultures. b Highly significant upregulation of ACTN2 in co-cultures both under
HGF + IGF-1 and in control groups after 14 d compared with 2 d. After 2 d of cultivation, the lowest levels of ACTN2 were demonstrated in MSC
monocultures. A 2.7-fold upregulation in unstimulated controls and 3.2-fold under HGF + IGF-1 was observed in MSC monocultures after 14 d.
The expression of ACTN2 was downregulated in stimulated and control Mb monocultures. Higher expression of ACTN2 was observed when Mb
were cultivated in control groups. (** = p ≤ 0.01). Mb of three different isolations as well as three replicates of each were used. One replicate of
MSC and L6 was used
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Furthermore, IGF-1 stimulation did not increase MEF2
at all and ACTN2 only during early time points. Com-
paring the level of myogenic differentiation amongst the
three different cell groups, the co-cultures and MSC
monocultures showed lower levels of myogenic marker
expressions compared with myoblast monocultures, es-
pecially during early growth factor stimulation. The re-
quirement of longer differentiation time periods for
MSCs might be a possible explanation for lower myo-
genic marker expression during early time points. This
is in accordance with previously published work, in
which time periods up to 6 weeks were used [45, 46].
Expression of MEF2 and ACTN2 leads towards the for-
mation of skeletal muscle [18, 29–33].
Beginning myogenic differentiation of MSCs upon
co-cultivation with myoblasts and under IGF-1 stimulation
We further analysed the effect of combined stimulation
with HGF + IGF-1 compared with HGF or IGF-1 only,
as well as under unstimulated conditions in a basal dif-
ferentiation medium containing DHS, L-Glutamin, dexa-
methasone and bFGF (Fig. 3). Co-cultures and MSC
monocultures were directly related to myoblast mono-
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Fig. 7 Myogenic differentiation in fibrin/fibrin-collagen-I gels. Markers are presented with mean +/- SD. a Real-time PCR of MEF2 in MSC and
myoblast (Mb) co-cultures cultivated in fibrin and fibrin-collagen-I gels. The expression of MEF2 was highly significantly upregulated over time in
5-mg/ml fibrin-collagen-I gels. MEF2 expression was significantly and highly significantly downregulated in other gel conditions. Expressions are
shown in x-fold difference compared with co-cultures cultivated in 2D in control medium. b Real-time PCR of ACTN2 in MSC and Mb co-cultures
cultivated in fibrin and fibrin-collagen-I gels. The expression of ACTN2 was highly significantly upregulated over time in 5-mg/ml fibrin-collagen
I-gels. ACTN2 expression was downregulated in other conditions, except 5-mg/ml fibrin-collagen-I gels with similar expression compared with the
control. Expressions are shown in x-fold difference compared with co-cultures cultivated in 2D in control medium. c Real-time PCR of different
myogenic markers (DES, MEF2, MyHC2, ACTN2) and IGFBPs (IGFBP-4, -5, -6) in co-cultures cultivated in fibrin-collagen-I gels and stimulated with
HGF and IGF-1 for 2 d. Expressions are demonstrated in x-fold difference compared with unstimulated cells cultivated in control (=1). Upregulation
of all myogenic markers under HGF + IGF-1 stimulation compared with unstimulated controls, MyHC2 significantly. (** = p≤ 0.01). (* = p≤ 0.05).
(# = p≤ 0.05 compared with unstimulated controls). Mb of three different isolations as well as three replicates of each were used
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higher levels of DES compared with co-cultures, prob-
ably because of desmin being a MSC marker [47].
MYOG expression could only be detected in one out of
three experiments and was limited to co-cultures, with
highest levels under HGF stimulation. Long-term stimu-
lation with IGF-1 showed increased levels of ACTN2
and MyHC2 in co-cultures, higher than in MSC and
myoblast monocultures, indicating that MSCs might
need longer differentiation periods [13, 48, 49]. Cell–cell
contact between myoblasts and MSCs could be a pos-
sible explanation for increased myogenic marker expres-
sion in co-cultures, comparable to previous findings by
Beier et al., in which elevated levels of MEF2 and
ACTN2 were detected upon direct co-cultivation of
MSCs and myoblasts [18]. In previous studies it has
been described that MSC influence myoblast differenti-
ation in a paracrine way [13, 16, 17].
With multicolour flow cytometry, the myogenic differ-
entiation on a protein level was further analysed.
Elevated levels of MEF2 and ACTN2 were detected in
co-cultures and MSC monocultures after 14 d of stimu-
lation with HGF + IGF-1 as well as in unstimulated con-
trols indicating an increasing myogenic differentiation
[30–33]. Under fluorescence microscopy, positive stain-
ing for MyHC2, part of the myosin motor protein and
therefore responsible for skeletal muscle contraction, re-
vealed further myogenic differentiation [50]. Through
stable transduced GFP expression, it was possible to de-
tect the involvement of MSCs in the formation of multi-
nucleated cells (Fig. 4). Cultivation in HGF/IGF-1 free
medium almost always achieved similar levels of myo-
genic differentiation than under HGF + IGF-1 stimula-
tion. We were not able to detect significant differences
between our stimulation and controls groups. Based on
this observation, these growth factors may not necessarily
be needed for sufficient myogenic differentiation [48, 49].
But then – what might be the explanation for adequate




Fig. 8 Cultivation of MSC-myoblast co-cultures on PCL-collagen-I nanofiber scaffolds. a-b SEM images of parallel-orientated PCL-collagen-I nanofiber
scaffold cell attachments. c-d Parallel orientation of MSCs (green) on PCL-collagen-I nanofibers. e Positive staining for desmin (red) of MSC-myoblast
co-cultures on PCL-collagen scaffolds. Nuclei were counterstained with DAPI (blue). Scale bars represent 200 and 100 μm. Magnifications 40x (c, e) and
100x (d)
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First of all, our HGF/IGF-1 free medium (or control
medium) contains already dexamethasone and bFGF, two
factors known to influence myogenic differentiation
[18, 51, 52]. Furthermore, as mentioned earlier, both
MSC and myoblasts are known to secrete several
growth factors involved in the muscle regeneration
process [13, 16, 17, 43]. Herein, autocrine and paracrine
stimulation might lead to myogenic differentiation. None-
theless, successful muscle generation depends on more
than secreted factors: cell-cell contact is crucial for a satis-
factory differentiation. Previous works by Singaravelu and
Padanilam compared the differentiation of MSC in condi-
tioned medium with co-cultivation of MSC and injured
renal cells. Cultivation in conditioned medium did not in-
duce differentiation, but co-cultivation led to differenti-
ation [53].
In summary, we successfully differentiated MSCs into
the myogenic lineage both under HGF/IGF-1 stimula-
tion and in a control medium, compared with myoblasts
on the mRNA level (MEF2, ACTN2, DES) as well as
after 14 d on the protein level (MEF2, ACTN2, MyHC2).
Upon co-cultivation with myoblasts and under IGF-1
stimulation, additional expression of key myogenic marker
MyHC2 could be detected.
Comparing the myogenic potential of MSCs upon co-
cultivation with myoblasts with MSC monocultures
could be a promising future prospect. We already tried
to separate MSCs by their GFP signal with fluorescence-
activated cell sorting, but the yield was not enough for
further analysis. In future experiments, it may be pos-
sible to sort MSCs for evaluation of myogenic potential
cultivated in co- compared with monocultures, using
higher cell numbers. Furthermore, only very low levels
of MYOG could be detected in co-cultures in our study.
MSC monocultures did not express MYOG at any time
point. Because myogenin is mostly expressed during ter-
minal stages of myogenic differentiation [54, 55], longer
cultivation periods of at least up to 28 d would be one
future goal. Although cell detachment after 28 d of culti-
vation made it impossible to analyse the gene expression
during longer observation periods so far, coating with
collagen type I or Maxgel™ (consisting of an undefined
composition of human extracellular matrix components)
may be a possibility to overcome cell detachment in
future experiments [56]. Furthermore, myogenin is
known to peak at some point of myoblast differenti-
ation and then decline to lower expression afterwards.
By the time we analysed myogenin expression, it might
be possible that its expression was already starting to de-
cline [57, 58].
Possible involvement of IGFBPs in myogenic differentiation
IGFBPs are a family of secreted proteins binding IGF-
1 and either potentiating or inhibiting IGF-1 actions
on myogenic differentiation [20, 22]. In our study, in
co-cultures, increased expression of IGFBP4, - 5 and -6
goes along with higher ACTN2 and MyHC2 expression
under IGF-1 stimulation compared with myoblasts and
MSC monocultures, accompanied by lower expressions of
DES and MYOG (MYOG was only detected in one out of
three experiments in co-cultures). IGFBP5 and -6 showed
a similar expression pattern amongst all conditions in co-
cultures, suggesting that these genes might have equal ef-
fects on myogenic differentiation and are regulated alike.
Furthermore, the expression of MyHC2 and ACTN2 ap-
pears to correlate with IGFBP5 and -6 in co-cultures, indi-
cating that they might have a positive influence on the
expression of those myogenic markers.
In MSC monocultures both under HGF + IGF-1 and
HGF stimulation, elevated levels of IGFBP4 as well as
ACTN2 were observed compared with co-cultures and
myoblast controls, whereas IGFBP5, -6 and MyHC2 ex-
pressions were almost undetectable.
Depending on the culture conditions (co-/monocultures),
growth factor stimulation and the analysed myogenic
markers, different effects could be detected. In co-
cultures under IGF-1, increased expression of IGFBPs
was observed together with elevated levels of ACTN2
and MyHC2, and MSC monocultures showed different
results under the same conditions. Hence, the func-
tion of the different IGFBPs might vary among differ-
ent surrounding conditions. So far, we presume that
IGFBPs play a role during myogenic differentiation.
Even though there is still no uniform opinion con-
cerning the exact function of the IGFBPs, IGFBP4
was both identified as a positive influencer during
muscle regeneration and as a potent inhibitor of
muscle growth and IGF-1 actions [20, 21, 59, 60].
IGFBP5 could inhibit IGF-1 actions, potentiate IGF-1
effects or act in an IGF-independent way [24, 61].
IGFBP6 may not act primarily during the myogenic
differentiation process [20].
Using ELISA or Western Blot, the concentrations of
IGFBPs in the cell lysate or the supernatant could be es-
timated more precisely. Inhibiting IGFBPs through
IGFBP antibodies could be another approach to gain
more information about these binding proteins and their
effects on IGF-1 and myogenic differentiation.
Three-dimensional environment enhances myogenic
differentiation of MSCs and myoblasts
Regarding the matrix evolution in TE, we previously
demonstrated that 3D collagen-I gels had a stimulatory
effect on myoblasts [27]. According to these findings,
we investigated the effect of 3D systems on co-
cultures of MSCs and myoblasts with HGF + IGF-1,
and observed a strong upregulation of myogenic key
markers compared with unstimulated groups. However,
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fibrin-collagen-I gels cannot provide the needed spatial
orientation for muscle tissue. Therefore, we developed
an electrospun, parallel-aligned, PCL-collagen-I nanofi-
ber scaffold as the basis for further generation of
muscle tissue. Parallel alignment of fibres stimulates
myotube formation, and the combination of PCL and
collagen provides strength, elasticity and compliance,
which is essential for the formation of functional tissue
[26, 62]. Cultivating MSCs and myoblasts on parallel-
oriented PCL-collagen-I nanofibers and stimulating
with HGF + IGF-1 for 7 d leads to parallel alignment
of the cells in this study, indicating that this scaffold
is a promising matrix for generation of muscle tissue
in vitro. Jana et al. cultivated C2C12 myoblasts on
aligned chitosan-PCL hybrid nanofiber scaffolds, show-
ing formation of a compact assembly of myotube cells
[63]. Zhao et al. used aligned electrospun PCL/collagen
hybrid scaffolds for diaphragmatic repair in rats, dem-
onstrating muscle cell migration and tissue formation
[64]. For further investigation of our results in vivo,
the newly developed arteriovenous loop model com-
bined with nervous innervation through the saphenous
nerve might offer a promising possibility for the func-
tionalization of skeletal muscle [65].
Although promising results for engineering of vas-
cularised tissue have already been achieved in the
case of bone reconstruction [66], free autologous
muscle flap transplantation still remains the gold
standard for muscle reconstruction, in particular for
complex soft tissue defects [67]. However, in the fu-
ture, TE of skeletal muscle may help to overcome the
donor site problem of harvesting large muscles of the
human body.
Conclusions
The generation of functional skeletal muscle tissue for
future in vivo applications is still challenging. In this
study we demonstrated that MSCs in monocultures
and in co-cultivation with myoblasts are able to differ-
entiate into the myogenic lineage by expressing key
myogenic markers such as desmin, MEF2, MyHC2 and
ACTN2. Stimulation with HGF and IGF-1 induces an
upregulation of different myogenic markers, but prob-
ably is not essential for myogenic differentiation.
IGFBPs play a role during myogenic differentiation,
varying amongst culture and stimulation conditions.
Three-dimensional cultivation of co-cultures enhances
the myogenic differentiation capacity. PCL-collagen
nanofibers especially represent a promising scaffold,
mimicking the structure of skeletal muscle and indu-
cing parallel alignment of MSCs and myoblasts. The
results of this study represent important starting
points for future studies and in vivo applications for
the TE of skeletal muscle.
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